drugset / Trial / NCT06641635
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Phase 3
Recruiting
440 enrolled
Peking Union Medical College Hospital
Peking University Cancer Hospital & Institute · collabRuijin Hospital · collabShandong Cancer Hospital and Institute · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The most common external beam radiotherapy fractionation scheme for cervical cancer is 45-50.4 Gy delivered in 25-28 fractions. However, prolonged treatment duration can lead to insufficient availability of medical resources. We hope to assess the safety and efficacy of moderated hypofractionated online adaptive radiotherapy in combination with brachytherapy in patients with cervical cancer in a multicenter study.
Timeline
- Start
- 2024-11-19
- Primary completion
- 2026-10-31
- Completion
- 2029-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | 40 mg/m2 | — |